Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Head & Neck 1Endocrine 1Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 11Sezary Syndrome 10Mycosis Fungoides 10Lymphoma, Large-Cell, Anaplastic 9Immunoblastic Lymphadenopathy 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Large B-Cell, Diffuse 8Lymphoma, Follicular 8Lymphoma 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Melanoma 7Lymphoma, Mantle-Cell 7Lymphoma, B-Cell, Marginal Zone 6Leukemia, Lymphocytic, Chronic, B-Cell 6Waldenstrom Macroglobulinemia 5Lymphoma, Non-Hodgkin 5Lymphoma, Large-Cell, Immunoblastic 5Hodgkin Disease 5Leukemia, Large Granular Lymphocytic 4Burkitt Lymphoma 4Lymphoma, T-Cell, Peripheral 3Lymphoma, T-Cell 3Lymphoma, Extranodal NK-T-Cell 3Leukemia, Myeloid, Acute 3Intraocular Lymphoma 3Congenital Abnormalities 3Subcutaneous panniculitis-like T-cell lymphoma 2Ovarian Neoplasms 2Neoplasms, Plasma Cell 2Multiple Myeloma 2

Interventions

veliparib 1Temozolomide 1Rose Bengal 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Immunotherapy 1Drug Therapy 1Dacarbazine 1Capecitabine 1Bortezomib 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoid Tumor × Bortezomib × Dermatologic × Clear all
NCT00580320 2016-08-18

Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma

Virginia Commonwealth University

Phase 1 Completed
17 enrolled
DermatologicEndocrineHead & NeckSarcomaThoracic

Carcinoid Tumor, Melanoma, Parathyroid Neoplasms, Sarcoma, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡